Jeffrey F. Eisenberg

This profile gathers the share dealings of Jeffrey F. Eisenberg across 2 companies, led by Mabvax Therapeutics Holdings, Inc. and Xenetic Biosciences, Inc. We count 4 filings; the first trade dates from 26 October 2017 and the latest from 24 January 2018.

On the market, this insider has only sold: 2 sales, €25k in total. Besides market trades, the filings include 1 share grant and 1 option exercise. So far in 2018, the count stands at no purchases and 2 sales.

Most recently, on 24 January 2018, the filings show an open-market sale worth €12k in Mabvax Therapeutics Holdings, Inc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.